Heartbeam Inc BEAT
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-10-14 |
| Shares Out. | 55,510,000 |
| Website | heartbeam.com/ ↗ |
| Phone | 14088994443 |
| Employees | 17 |
| Net Income | -$4.7M |
| Free Cash Flow | -$14.0M |
| Total Assets | $3.9M |
| Total Liabilities | $3.3M |
| Equity | $635,000 |
About Heartbeam Inc
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Heartbeam Inc is a publicly traded company under the ticker symbol BEAT on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)